ETIDRONATE AND THE RISK OF FRACTURES
Authors:
- C.NAgantde DeuxchaisnesCDC.NAgantde Deuxchaisnes
- J.P. DevogelaerJDJ.P. Devogelaer
- J.P. HuauxJHJ.P. Huaux
- W. EsselinckxWEW. Esselinckx
- 1 September 1985
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 326 (8455) , 610-611
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Untreated Paget disease of bone studied by scintigraphy.Radiology, 1984
- FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASEThe Lancet, 1984
- Treatment of Paget's disease of boneMedical Journal of Australia, 1983
- Review of Fracture Experience During Treatment of Paget's Disease of Bone with Etidronate Disodium (EHDP)Clinical Orthopaedics and Related Research, 1983
- Musculoskeletal manifestations of paget's disease of boneArthritis & Rheumatism, 1980
- Use of etidronate (ehdp) in paget's disease of boneArthritis & Rheumatism, 1980
- PAGETʼS DISEASE OF BONEMedicine, 1964